Motif Prediction of Abemaciclib in a Breast Cancer Cell Line Using ChIP-Seq Data Analysis. Biomed. Res. Ther. 2022, 9 (3), 4971-4985. https://doi.org/10.15419/bmrat.v9i3.732.